SpringWorks Therapeutics, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$5.3M
Doctors Paid
2,426
Transactions
5,727
2024 Total
$5.3M
Payment Breakdown by Category
Research$3.9M (74.1%)
Consulting$310,945 (5.9%)
Food & Beverage$118,638 (2.3%)
Travel$61,901 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.9M | 1,310 | 74.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $797,466 | 152 | 15.2% |
| Consulting Fee | $310,945 | 101 | 5.9% |
| Food and Beverage | $118,638 | 3,835 | 2.3% |
| Grant | $75,500 | 14 | 1.4% |
| Travel and Lodging | $61,901 | 315 | 1.2% |
Payments by Type
Research
$3.9M
1,310 transactions
General
$1.4M
4,417 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| MEK-NF-201 | $1.3M | 0 | 209 |
| NIR-DT-301 | $640,824 | 0 | 107 |
| NIR-OGT-201 | $578,667 | 0 | 607 |
| MEKRAF-AST-101 | $520,520 | 0 | 300 |
| TEAD-AST-101 | $313,065 | 0 | 75 |
| A PHASE II STUDY OF CRYOABLATION PLUS NIROGACESTAT FOR DESMOID TUMOR | $214,983 | 0 | 5 |
| PHASE 1B/2A, OPEN -LABEL PLATFORM STUDY TO EVALUATE MIRDAMETINIB AS MONOTHERAPY OR IN COMBINATION WITH OTHER ANTICANCER AGENTS IN PATIENTS WITH ADVANCED SOLID CANCERS HAROBIRING MAPK-ACTIVATING TUMORS | $49,602 | 0 | 1 |
| A SAFETY,PHARMACOKINETIC AND EFFICACY STUDY OF A ?-SECRETASE INHIBITOR, NIROGACESTAT IN CHILDREN AND ADOLESCENTS WITH PROGRESSIVE, SURGICALLY UNRESECTABLE DESMOID TUMORS | $11,740 | 0 | 1 |
Payments by Medical Specialty
About SpringWorks Therapeutics, Inc.
SpringWorks Therapeutics, Inc. has made $5.3M in payments to 2,426 healthcare providers, recorded across 5,727 transactions in the CMS Open Payments database. In 2024, the company paid $5.3M. The top product by payment volume is OGSIVEO ($493,656).
Payments were distributed across 79 medical specialties. The top specialty by payment amount is Hematology & Oncology ($199,702 to 763 doctors).
Payment categories include: Food & Beverage ($118,638), Consulting ($310,945), Research ($3.9M), Travel & Lodging ($61,901).
SpringWorks Therapeutics, Inc. is associated with 1 products in the CMS Open Payments database.